Barry Richard's Form 4 filing
Filana Therapeutics, Inc. (FLNA) · filed Nov 20, 2025
- Accession no.
- 0001437749-25-035882
- Filed
- Nov 20, 2025
- Trade date
- Nov 19, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $201.8K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Barry RichardCIK 0001562371 | Director, Officer (President & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 19, 2025 | Common Stock | PPurchaseAcquired | +73,385 | $2.75 | +$201,808.75 | 788,060 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.